HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical and statistical study of 121 cases of acute myocardial infarct from 1976 to 1981 (month of April). Critical review].

Abstract
The authors realized a retrospective clinical-statistical study about 121 cases of acute myocardial infarction (AMI), treated in the Department of general medicine with a pharmacological association of Lysine acetylsalicylate--Erythrityl tetranitrate--Papaverine hydrochloride, with the purpose of obtaining a vasodilatation on coronary arteries and a platelet antiaggregation, in the light of the new etiopathogenetic views about the prolonged coronary spasm and the platelet aggregation, in some cases of myocardial infarction with or without thrombosis. Obtained data are very optimistic about incidence of left ventricular insufficiency and (of) thromboembolisms, to they augur the sistematic adoption of this treatment of AMI, especially as to the early antiaggregation therapy.
AuthorsL Carile, G A Laquaglia, P Martone, F Marchionni, C Di Falco
JournalMinerva medica (Minerva Med) Vol. 73 Issue 14 Pg. 821-7 (Apr 02 1982) ISSN: 0026-4806 [Print] Italy
Vernacular TitleStudio clinico-statistico su 121 casi di infarto miocardico acuto (IMA) dal 1976 al 1981 (mese di aprile). Revisione critica.
PMID6803194 (Publication Type: Journal Article)
Chemical References
  • Erythrityl Tetranitrate
  • Papaverine
  • Lysine
  • Aspirin
  • acetylsalicylic acid lysinate
Topics
  • Adult
  • Aged
  • Aspirin (analogs & derivatives, therapeutic use)
  • Coronary Vessels (drug effects)
  • Erythrityl Tetranitrate (therapeutic use)
  • Female
  • Heart Failure (prevention & control)
  • Humans
  • Lysine (analogs & derivatives, therapeutic use)
  • Male
  • Middle Aged
  • Myocardial Infarction (drug therapy)
  • Papaverine (therapeutic use)
  • Platelet Aggregation (drug effects)
  • Retrospective Studies
  • Thromboembolism (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: